Application no. and date | 09150953.9 (espacenet) (Federated) (European Patent Register), 20000407 | Patent/reg. no. and date | DK/EP 2077268, 20170301 | Publication date | 20090708 | Priority no. and date | NZ 33509099, 19990408, NZ 33616899, 19990608 | EP pub. no. and date |
EP 2077268 20090708 | Effective date | | Applicant/owner | Albert Einstein College of Medicine, Inc., 1300 Morris Park Avenue
Bronx, NY 10461, US, Victoria Link Limited, EA 120, Easterfield Building Kelburn Parade
Wellington 6140, NZ | Applicant ref. no. | BBS84740EPDK | Inventor | SCHRAMM, Vern L., 68 Hampton Oval
New Rochelle, NY 10805, US, Furneaux, Richard Hubert, 35 Huntington Street Witon
6005, Wellington, NZ, Tyler, Peter Charles, 143 Creswick Terrace, Northland
6001, Wellington, NZ | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | Opponent | | IPC Class | C07D 207/34 (2006.01) , C07D 487/04 (2006.01) , C07D 519/00 (2006.01) , C07F 7/18 (2006.01) | Title | Fremgangsmåde til fremstilling af hæmmere af nukleosidmetabolisme | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|